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ORIGINAL ARTICLE
Background/Aims: Many prognostic models have been developed to help physicians make medical decisions
on treating patients with pulmonary embolism. Among these models, the Pulmonary Embolism Severity Index
(PESI) has been shown to be a successful risk stratification tool for patients with acute pulmonary embolism. The
PESI, however, had not been applied to patients with pulmonary embolism in Korea.
Methods: The patients included in this study were diagnosed by computed tomography at Inje University’s Ilsan
Paik Hospital between December 1999 and March 2007. Risk stratification for the patients was performed using
the PESI. The mortality rate was calculated according to each PESI risk class.
Results: Of the 90 patients enrolled in this study, ten were assigned to PESI class I, 29 to PESI class II, 22 to
PESI class III, eight to PESI class IV, and ten to PESI class V. The mortality rate after 30 days in each class was
0, 10.3, 9.1, 0, and 50% (p=0.0016), respectively, whereas the respective hospital mortality rate was 4.8, 13.8,
13.6, 12.5, and 50% (p=0.0065). The overall mortality was 9.5, 27.6, 31.8, 50.0, and 60%, respectively (p=0.0019).
The mortality rate was significantly associated with the PESI class. 
Conclusions: The PESI class was found to be significantly correlated with the 30-day mortality rate, hospital
mortality, and overall mortality. Our data indicate that the PESI can be used to predict the prognosis of patients
with pulmonary embolism and in making medical decisions regarding the treatment of patients with pulmonary
embolism. (Korean J Intern Med 2009;24:123-127)
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INTRODUCTION
Pulmonary embolisms occur relatively frequently, with
23 cases per 100,000 annually in the United States [1].
However, since its clinical features are nonspecific, a
diagnosis of pulmonary embolism is not easy to make.
Furthermore, without appropriate treatment, a pulmonary
embolism can be fatal. Therefore, suspecting such a
condition and evaluating it appropriately is important in
making a prognosis. Once a prognosis has been made, the
mortality rate can be lowered through proper treatment.
However, while significant effort has been made to
clarify the risk factors and treatment of pulmonary
embolism, relatively little data are available regarding a
prognostic index. Nevertheless, since the development
of the Geneva score [2] in 2000 and the Pulmonary
Embolism Severity Index (PESI) [3] in 2005, two models
have been introduced as prognostic-predictive indexes.
Of these, the PESI has been shown to have higher predic-
tive accuracy [4].
Ostensibly, Koreans may appear to have fewer risk
factors for pulmonary embolism, such as obesity or deep
vein thrombosis, compared to people in the West, and
may thus be expected to suffer from pulmonary embolismsless often and have a better prognosis than Westerners.
[5,6] However, at present few data exist to support this
assertion or the utility of the PESI for Korean patients
with pulmonary embolism. For this reason, we analyzed
the usefulness of the PESI as presented by Aujesky et al
[3] with regard to predicting the prognosis of Korean
patients with pulmonary embolism.
METHODS
Patient Enrollwent
Between December 1999 and March 2007, we enrolled
195 hospitalized patients or outpatients at Inje University’s
Ilsan Paik Hospital diagnosed with acute pulmonary
embolism according to the Korean Classification of
Diseases (KCD). Of these patients, 84 with an inadequate
diagnosis (i.e., pulmonary embolism was not confirmed
by computed tomography (CT)) and 21 for whom survival
or mortality could not be established through medical
records or a phone call or whose preserved medical records
were not sufficiently substantial to apply the PESI were
excluded. Thus, 90 patients were evaluated in this study. 
Study Design
In December 1999, we identified those patients for
whom pulmonary embolism was confirmed by chest CT
and analyzed their medical records. The age, sex, past
medical history, combined disease, and clinical symptoms
of the patients were considered in addition to the 11
indices included in the PESI [3].
According to the method suggested by Aujesky et al [3],
points were given as follows: 1 for each year of age, 10 for
male sex, 20 for a heart rate >110 beats/min, 30 for
cancer, 10 for heart failure, 10 for chronic lung disease, 30
for a systolic pressure <100 mmHg, 20 for a respiratory
rate >30 times/min, 20 for a body temperature <36˚C, 60
for an altered mental state, and 20 for an arterial oxygen
saturation value <90%. Based on the point distribution, a
score below 65 was classified as PESI class 1, 66-85 as
class II, 86-105 as class III, 106-125 as class IV, and over
126 as class V [3].
Among the items included in the PESI, arterial oxygen
saturation was measured with an arterial blood gas
analysis or a pulse oximeter. For those cases in which no
actual measurement was made, a case of respiratory
distress requiring oxygenation was recorded.
The subjects were reviewed on the basis of their past
history and combined disease, such as diabetes, hyperten-
sion, or cerebral hemorrhage, as well as a history of surgery
requiring general anesthesia. For the clinical symptoms,
we examined four vital signs to assess whether the patient
had respiratory distress altering his/her consciousness
and required oxygenation. 
Survival was confirmed through the use of medical
records or a phone call. Patients with unknown survival
were excluded from the subject group. 
Data analysis and statistics
The data were analyzed using basic technological
statistics. Our results indicated that the higher the class,
the higher the mortality rate. This tendency was measured
using the chi-square test for trends, and a significance
level of 0.01 was applied. For the statistical management
of the data, we used SPSS for Windows (version 11.0) and
MedCalc (version 9.5.1). 
RESULTS
Basal Characteristics
Of the 90 patients included in this study, 37 (41.1%)
were men and 53 (58.9%) were women, resulting in a
male-to-female ratio of 1:1.4. The average age of the
patient group (±standard deviation) was 60.4 (±16.0)
years of age (Table 1). None of the patients was between
the ages of ten and 20, whereas five were in their 20s
(5.6%), ten were in their 30s (11.1%), 11 were in their 40s
(12.2%), ten were in their 50s (11.1%), 22 were in their 60s
(24.4%), 29 were in their 70s (32.2%), and three were in
their 80s (3.3%). 
Comorbidities of the Subjects
Thirty-nine patients (43.3%) had hypertension, 12
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Table 1. Baseline characteristics
Number (%)
Sex, male 37 (41.1)
Age (years, mean±SD) 60.4±16.0
Comorbitidy
Hypertension 39 (43.3)
Operation 26  (28.9)
Malignancy 16 (17.8)
DM 12 (13.3)
Stroke 10 (11.1)
Emphysema 9 (10)(13.3%) had diabetes, and 16 (17.8%) had either been
diagnosed with cancer or were being treated for cancer.
Nine patients (10%) were confirmed as having emphysema
through chest CT, while ten patients (11.1%) had a cerebral
hemorrhage and cerebral infarction, and 26 (28.9%) had a
surgical history (Table 1). 
PESI Classificatich
With regard to the distribution of the patients according
to their PESI risk class, 21 (23%, 34-65 points, average:
49.9 points) patients were in class I (<65 PESI points), 29
(32%, 67-85 points, average: 77.6 points) were in class II
(66-85 PESI points), 22 (25%, 88-105 points, average:
77.6 points) were in class III (86-105 PESI points), eight
(9%, 106-121 points, average: 71.1 points) were in class IV
(106-125 PESI points), and ten (11%, 145-245 points,
average: 187 points) were in class V (>126 PESI points);
thus, most of the patients were in class II while the smallest
number were in class IV (Fig. 1).
Mortality rate base on the PESI
The mortality rate after 30 days, mortality rate during
hospitalization, and total mortality rate were compared
according to the PESI risk classes of the patients. At 30
days, the mortality rate was 11.1%. When this result was
analyzed according to PESI class, a significant trend
toward increased mortality with a higher class was
detected (p=0.0016), with 0% in class I, 10.3% in class II,
9.1% in class III, 0% in class IV, and 50% in class V. In
considering the 0% mortality rate detected for class IV,
note that the average hospital stay for this group was 10
days shorter than that for the other groups; thus, the
possibility of underestimation exists. In comparison, the
hospital mortality rate was 15.6%; when it was analyzed
according to PESI class, a significant trend (p=0.0065)
was observed, with 4.8% in class I, 13.8% in class II, 13.6%
in class III, 12.5% in class IV, and 50% in class V (Fig. 2).
The total mortality rate was 30%; when it was analyzed
according to PESI class, an increasing tendency toward
the higher class was observed, with 9.5% in class I, 27.6%
in class II, 31.8% in class III, 50% in class IV, and 60% in
class V (p=0.0019) (Fig. 3). 
Mortality rate of the redistri-buted PESI
Grouping of the PESI classes into low- (class I),
intermediate- (classes II-IV), and high-risk (class V)
groups produced a 30-day mortality rate of 0, 8.2, and
50%, respectively. Compared to the results before the
redistribution, the tendency was quite clear (p=0.0016
→0.0003). The mortality rate during hospitalization was
4.8, 13.1, and 50% for the low-, intermediate-, and high-
risk groups, respectively, and the tendency was much
clearer (p=0.0065→0.0038), as was the 30-day mortality
rate. The total mortality rate was 9.5, 31.1, and 60% for the
low-, intermediate-, and high-risk groups, respectively,
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Figure 1. Patients distribution according to PESI risk class.
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Figure 2. Hospital mortality according to PESI risk classification.
PESI, pulmonary embolism severity index; NS, not significant.
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Figure 3. Overall mortality according to PESI risk classification.
PESI, pulmonary embolism severity index; NS, not significant.
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DISCUSSION
Various mortality rates have been reported for patients
with pulmonary embolism (from 2 to 95%) [7-9]. Based
on our data, the 30-day mortality rate was 11.1%, whereas
the mortality rate during hospitalization was 15.6% and
the total mortality rate was 30.0%. We suspect that the
reported mortality rates were inconsistent because each
patient had several confounding factors that may have
affected his/her prognosis, such as different combined
diseases and different degrees of pulmonary embolism.
However, few reports have addressed the factors that can
affect a prognosis or the predictive factors of pulmonary
embolism.
To create a prognostic-predictive system for patients
with pulmonary embolism, the Geneva score [2] was
developed in 2000, whereas the PESI [3] was first
presented in 2005. Since that time, the PESI has been
shown to be a slightly better system for making pro-
gnoses [4].
Aujesky et al. [3] reported that the 30-day mortality
rate was 0.8-27.1% for PESI classes I-V, claiming that
patients in a higher PESI class had a tendency toward an
increased mortality rate. Thereafter, when the PESI was
applied to Koreans, the 30-day mortality rate, mortality
rate during hospitalization, and total mortality rate were
0-60%. Since all of the results were significant, the PESI
may be useful in predicting the prognosis of Korean
patients with pulmonary embolism (30-day mortality:
p=0.0016, hospital mortality: p=0.0065, and overall
mortality: p=0.0019). 
Aujesky et al [3] asserted that the PESI could be used
to identify low-risk groups and to develop a treatment
plan. They reported that the 30-day mortality rate for
patients in PESI classes I and II was below 1.6 and 3.5%,
respectively. The risk of hemorrhage and the frequency of
a recurrence of pulmonary embolism during treatment
were shown to be lower. They also claimed that in class I
and II patients, low-molecular-weight heparin could be
used safely, even in outpatients, and that these patients
were in fact a low-risk group [10]. However, when the 30-
day mortality rate was examined according to PESI
class in Korean patients, the value for the class I patients
was 0%, while that for the class II patients was 10.3%,
reflecting a significant difference between these groups.
Therefore, as was determined by Aujesky et al. [3], the
patients in PESI class II were difficult to treat through
ambulatory care. The mortality rate during hospitalization
(class I: 4.8%, class II: 13.8%) (p=0.029) and the total
mortality rate (class I: 9.5%, class II: 27.6%) (p=0.115)
were not statistically meaningful, but a difference was
seen between the two groups. This should be considered
because the number of subjects in PESI class I was 21
while the number in PESI class II was 29. Thus, regarding
both PESI classes I and II as low-risk groups for outpatient
treatment could be dangerous. 
The patients in PESI classes II-IV, however. showed
a similar 30-day mortality rate, mortality rate during
hospitalization, and total mortality rate. In classes II-IV,
the higher classes did not have a tendency toward an
increased mortality rate (p=0.424, 0.995, and 0.281,
respectively), and when PESI classes II-IV were
redistributed as an intermediate-risk group, the higher
classes had a clear tendency toward an increased mortality
rate (30-day mortality: p=0.0016→0.0003, hospital
mortality: p=0.0065→0.0038, and overall mortality:
p=0.0019→0.0034). 
Therefore, if the PESI classes were redistributed as low-
(class I), intermediate- (class II-IV), and high-risk (class
V) groups, the convenience, feasibility, and accuracy of the
prognostic-predictive index would be improved. When
mortality rates were compared among the groups, the 30-
day mortality rate in the low-, intermediate-, and high-risk
groups was 0, 8.2, and 50%, respectively, while the
mortality rate during hospitalization was 4.8, 13.1, and
50%, respectively. In comparison, the total mortality rate
was 9.5, 31.1, and 60%, respectively  (Table 2).
To determine an appropriate treatment plan for pulmo-
nary embolism, the most important considerations are the
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Table 2. Hospital mortality and overall mortality according to redistributed PESI risk class
Low Intermediated High p value
(class I) (class II - IV) (class V)
30 day mortality (%) 0 (0) 5 (8.2) 5 (50) 0.000
Hospital mortality (%) 1 (4.8) 8 (13.1) 5 (50) 0.004
Overall mortality (%) 2 (9.5) 19 (31.1) 6 (60.0) 0.021
Data are expressed in total number (%)patient’s hemodynamic stability and echocardiographic
findings. In this study, right ventricular dyskinesia was
observed in three of 75 patients who had taken an echo-
cardiogram; notably, one of these patients was in PESI
class III and the other two were in PESI class IV, indica-
ting that all instances occurred in the relatively higher
PESI classes. This suggests that the PESI score can be
used to determine a treatment plan for those patients in
high-risk groups as well as for patients in low-risk groups. 
This study has the intrinsic restrictions of any retro-
spective study, including inconsistencies in patient
selection and the treatment plan. It was also based on a
relatively small number of patients (n=90) for whom the
causes of death were not classified. However, to improve
the accuracy of our results, only those cases in which
pulmonary embolism was confirmed through chest CT
were included. In addition, the use of phone calls enabled
us to conduct a relatively long-term follow-up to confirm
the 30-day mortality rate, as well as the mortality rate
during hospitalization and the total mortality rate. This
study indicates that the PESI is a helpful predictor, not
just of the 30-day mortality rate but also of the mortality
rate during hospitalization and the total mortality rate.
Risk group classification using the PESI can predict
not only the 30-day mortality rate but also the mortality
rate during hospitalization and the total mortality rate,
indicating that it is a relatively accurate prognostic-
predictive index. Our work suggests that the use of
comparative data incorporating hemodynamic stability
and echocardiographic findings in conjunction with a
prospective approach can be used to develop a standard
treatment plan index for pulmonary embolism.
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